The Cigna Group (NYSE:CI) has caught the attention of Wall Street analysts as they closely monitor its performance. Recently, Lance Wilkes, an analyst at Bernstein, adjusted the price target on The Cigna Group to $294 from $346, while maintaining a ‘Market Perform’ rating on the stock. The firm highlighted the company’s new pharmacy benefit manager (PBM) model as being more sustainable but stated that they were not expecting a valuation rerating just yet following the release of the company’s third-quarter earnings report.
In the third quarter, The Cigna Group reported revenue of $69.7 billion, a 10% increase from the same quarter in 2024, and adjusted earnings of $7.83 per share, up from $7.51 per share in the previous year. The company managed to achieve these results while continuing to invest in driving growth and innovation, according to management.
Several analysts made adjustments to their outlook on The Cigna Group in early November. TD Cowen reduced the price target on CI to $333 from $387 but reiterated a ‘Buy’ rating on the stock. JPMorgan also maintained an ‘Overweight’ rating while revising the price target to $375 from $428 on the same day.
Founded in 1792 and based in Connecticut, The Cigna Group is a provider of insurance and related products and services through its subsidiaries. The company operates through Evernorth Health Services and Cigna Healthcare segments.
While The Cigna Group shows promise as an investment, some analysts believe that certain AI stocks offer greater upside potential with less downside risk. For investors looking for an undervalued AI stock that could benefit from current economic trends, a free report on the best short-term AI stock is available.
In conclusion, The Cigna Group continues to be a stock to watch closely as it navigates the ever-changing landscape of the healthcare industry. With strong financial performance and strategic investments in growth and innovation, the company remains well-positioned for future success. Investors should keep an eye on updates from analysts and management to stay informed about the company’s trajectory.
